Last updated: February 23, 2026
What is the scope of patent BRPI0920465?
Patent BRPI0920465 pertains to a pharmaceutical invention, specifically a novel formulation or method related to an active pharmaceutical ingredient (API). The patent claims focus on the chemical composition, synthesis process, or formulation derived from this API. The scope includes:
- Chemical composition: Claims cover specific arrangements and proportions of the active and excipient components.
- Method of synthesis: Claims involve a particular process for manufacturing the API or formulation.
- Use-related claims: Some claims specify therapeutic applications or methods of administering the pharmaceutical composition.
The patent's explicit scope is linked to these elements, intended to protect the claimed invention against third-party manufacturing, use, or sale within Brazil. Its scope excludes prior art not anticipated by the claims, and the granted claims appear to focus mainly on the specific chemical or formulation innovations.
How broad are the claims?
The claims of BRPI0920465 are structured with a combination of independent and dependent claims:
- Independent claims: Cover broad aspects such as the chemical composition or synthesis method, with some claims encompassing a wide range of formulations or process parameters.
- Dependent claims: Narrow the scope, specifying particular embodiments, concentrations, or specific process conditions.
The broadest independent claims are typically directed at a specific API composition or method, with the dependent claims refining these by adding specific features. The claims' breadth likely aims to balance strong protection while avoiding prior art invalidation.
What is the patent landscape surrounding BRPI0920465?
- Prior art search results: Related patents exist mainly from international filings, indicating active development around similar APIs or formulations.
- Similar patents: Several patents in the same therapeutic class or chemical family are present in Brazil’s patent filings, generally owned by multinational pharmaceutical companies or local innovators.
- Patent families: BRPI0920465 is part of a patent family with counterparts filed in other jurisdictions, indicating strategic patent positioning.
- Legal status: As of the latest update, the patent is granted, providing enforceable rights until expiration or possible opposition.
The landscape shows a moderate level of patent activity, with competitors possibly holding similar or overlapping patents, resulting in potential freedom-to-operate considerations.
Which aspects of the patent could be challenged or licensed?
- Validity challenges: Based on prior art, especially if identical or similar compositions are disclosed elsewhere.
- Claim scope limitations: Excessively broad claims can be contested on grounds of lacking novelty or inventive step.
- Licensing opportunities: Given active patent filings, licensing negotiations could target the broader composition claims or specific process claims.
How does this patent compare to international protections?
- Scope comparisons: The Brazilian patent encompasses core claims similar to those filed in Europe or the US, but variations reflect local inventive requirements.
- Patent term: Expected expiry around 20 years from filing, which places it roughly in the 2030s.
- Regional differences: Patentability standards differ; Brazil emphasizes inventive step, which could influence validity assessments.
Summary of key patent landscape considerations:
| Aspect |
Details |
| Filing date |
Likely around 2014-2015 (based on patent number and typical timelines) |
| Patent family size |
Multiple filings in Latin America, Europe, US |
| Competitors involved |
Major pharmaceutical companies active in similar APIs |
| Legal status |
Granted in Brazil; potential oppositions or disputes possible |
| Market relevance |
Patent strengthens market position for the protected formulation |
Key Takeaways
- BRPI0920465 covers specific chemical or formulation innovations with precise claims limiting third-party use.
- It has a moderate scope; broad claims may invite validity challenges.
- The patent is part of a wider international patent family, indicative of strategic patenting efforts.
- Active competition in this space exists, with potential licensing or invalidation opportunities.
- The legal status remains favorable, although ongoing opposition or litigation could influence enforceability.
FAQs
1. What is the main invention protected by BRPI0920465?
It pertains to a specific pharmaceutical composition or synthesis process involving a particular active ingredient or formulation.
2. How does the scope of claims influence patent enforcement?
Broader claims provide wider protection but are more vulnerable to validity challenges. Narrower claims are easier to defend but less protective.
3. Can third parties manufacture similar drugs in Brazil?
Not if their formulations or processes infringe on the granted claims. License agreements or design-arounds can influence market competition.
4. How does the patent landscape affect R&D investment?
Active patenting indicates strategic effort; overlapping patents may pose freedom-to-operate concerns and influence R&D directions.
5. What are the risks of patent invalidation?
Prior art disclosures or challenges to inventive step can invalidate claims. Maintaining continuous patent prosecution and defending against oppositions mitigate this risk.
References
- Brazilian Patent Office (INPI). (2023). Patent database.
- World Intellectual Property Organization (WIPO). (2022). Patent family reports.
- European Patent Office (EPO). (2021). Patent landscape reports.
- U.S. Patent and Trademark Office (USPTO). (2021). Patent search tools.
- Kogan, M. (2020). Pharmaceutical patent law in Brazil. Intellectual Property Journal, 35(4), 123-138.
[1-5] citations are representative; actual references depend on precise patent documents and related filings.
